[47]
Similarly, Novopharm argues that Rule 152 automatically leads to a Protective Order. Abbott says this is clearly wrong. Like s. 6(8) of the
Regulations
, Rule 152 simply sets out a mechanism for the treatment of documents that are confidential. It cannot take away the Court's duty to examine necessity, and other aspects of the
Sierra Club
test, before it specifically orders that information and documents will be excluded from the public record under a Protective Order.
(ii) Should a protective order be granted on the grounds that Novopharm has met the normal test for the issuance of such orders?
Novopharm